Manifesto on united airways diseases (UAD): an Interasma (global asthma association – GAA) document
Open Access
- 5 March 2021
- journal article
- research article
- Published by Taylor & Francis in Journal of Asthma
- Vol. 59 (4) , 639-654
Abstract
The large amount of evidence and the renewed interest on upper and lower airways involvement in infectious and inflammatory diseases has led Interasma (Global Asthma Association) to take a position on United Airways Diseases (UAD). Starting from an extensive literature review, Interasma excecutive committee discussed and approved this Manifesto developed by Interasma scientific network (INES) members. The manifesto describes the evidence gathered to date and defines, states, advocates, and proposes issues on UAD (rhinitis, rhinosinusitis and nasal polyposis), and concomitant/comorbid lower airways disorders (asthma, chronic obstructive pulmonary disease, bronchiectasis, cystic fibrosis, obstructive sleep apnoea) with the aim of challenging assumptions, fostering commitment, and bringing about change. UAD refer to clinical pictures characterized by the coexistence of upper and lower airways involvement, driven by a common pathophysiological mechanism, leading to a greater burden on patient’s health status and requiring an integrated diagnostic and therapeutic plan. The high prevalence of UAD must be taken into account. Upper and lower airways diseases influence disease control and patient’s quality of life. Patients with UAD need to have a timely and adequate diagnosis, treatment, and, when recommended, referral for management in a specialized center. Diagnostic testing including skin prick or serum specific IgE, lung function, fractional exhaled nitric oxide (FeNO), polysomnography, allergen-specific immunotherapies, biological therapies and homebased continuous positive airway pressure (CPAP) whenever these are recommended, should be part of the management plan for UAD. Education of medical students, physicians, health professionals, patients and caregivers on the UAD is needed.Keywords
This publication has 176 references indexed in Scilit:
- Aspirin desensitization for patients with aspirin-exacerbated respiratory disease: A randomized double-blind placebo-controlled trialClinical Immunology, 2015
- Association and management of eosinophilic inflammation in upper and lower airwaysAllergology International, 2015
- Chronic rhinosinusitis and nasal polyposis in cystic fibrosis: update on diagnosis and treatmentJornal Brasileiro de Pneumologia, 2015
- Sinonasal inhalation of dornase alfa administered by vibrating aerosol to cystic fibrosis patients: A double-blind placebo-controlled cross-over trialJournal of Cystic Fibrosis, 2014
- The Frequency of Chronic Rhinosinusitis/Nasal Polyp in COPD and Its Effect on the Severity of COPDCOPD: Journal of Chronic Obstructive Pulmonary Disease, 2011
- Rhinobronchial syndrome: Pathogenesis and correlation with allergic rhinitis in childrenInternational Journal of Pediatric Otorhinolaryngology, 2008
- Effects of zafirlukast on bronchial asthma and allergic rhinitisPharmacological Research, 2003
- Cytokine expression in the lower airways of nonasthmatic subjects with allergic rhinitis: Influence of natural allergen exposureJournal of Allergy and Clinical Immunology, 2000
- United airways disease: therapeutic aspectsThorax, 2000
- One Airway, One DiseaseChest, 1997